Literature DB >> 28276670

Force degradation behavior of glucocorticoid deflazacort by UPLC: isolation, identification and characterization of degradant by FTIR, NMR and mass analysis.

Rajesh Deshmukh1, Lata Sharma2, Muktika Tekade3, Prashant Kesharwani4, Piyush Trivedi2, Rakesh K Tekade5,6.   

Abstract

In this investigation, sensitive and reproducible methods are described for quantitative determination of deflazacort in the presence of its degradation product. The method was based on high performance liquid chromatography of the drug from its degradation product on reverse phase using Acquity UPLC BEH C18 columns (1.7 µm, 2.1 mm × 150 mm) using acetonitrile and water (40:60 V/V) at a flow rate of 0.2 mL/minute in UPLC. UV detection was performed at 240.1 nm. Deflazacort was subjected to oxidative, acid, base, hydrolytic, thermal and photolytic degradation. The drug was found to be stable in water and thermal stress, as well as under neutral stress conditions. However, forced-degradation study performed on deflazacort showed that the drug degraded under alkaline, acid and photolytic stress. The degradation products were well resolved from the main peak, which proved the stability-indicating power of the method. The developed method was validated as per ICH guidelines with respect to accuracy, linearity, limit of detection, limit of quantification, accuracy, precision and robustness, selectivity and specificity. Apart from the aforementioned, the results of the present study also emphasize the importance of isolation characterization and identification of degradant. Hence, an attempt was made to identify the degradants in deflazacort. One of the degradation products of deflazacort was isolated and identified by the FTIR, NMR and LC-MS study.
© 2016 by the Journal of Biomedical Research. All rights reserved.

Entities:  

Keywords:  Deflazacort; characterization; degradant; forced degradation

Year:  2016        PMID: 28276670      PMCID: PMC4820892          DOI: 10.7555/JBR.30.20150074

Source DB:  PubMed          Journal:  J Biomed Res        ISSN: 1674-8301


  26 in total

1.  Ruggedness/robustness evaluation and system suitability test on United States Pharmacopoeia XXVI assay ginsenosides in Asian and American ginseng by high-performance liquid chromatography.

Authors:  Yong-Guo Li; Ming Chen; Gui-Xin Chou; Zheng-Tao Wang; Zhi-Bi Hu
Journal:  J Pharm Biomed Anal       Date:  2004-09-03       Impact factor: 3.935

Review 2.  System suitability in bioanalytical LC/MS/MS.

Authors:  Chad J Briscoe; Mark R Stiles; David S Hage
Journal:  J Pharm Biomed Anal       Date:  2007-03-13       Impact factor: 3.935

3.  An investigation of the dose proportionality of deflazacort pharmacokinetics.

Authors:  N Rao; V O Bhargava; D L Reynolds; M G Eller; S J Weir
Journal:  Biopharm Drug Dispos       Date:  1996-12       Impact factor: 1.627

4.  Isolation and characterization of a degradation product of deflazacort.

Authors:  A S Paulino; G Rauber; A M Deobald; N Paulino; A C H F Sawaya; M N Eberlin; S G Cardoso
Journal:  Pharmazie       Date:  2012-06       Impact factor: 1.267

5.  Compared clinical efficacy and bone metabolic effects of low-dose deflazacort and methyl prednisolone in male inflammatory arthropathies: a 12-month open randomized pilot study.

Authors:  G Saviola; L Abdi Ali; S Shams Eddin; A Coppini; F Cavalieri; L Campostrini; S Sacco; M Bucci; G Cirino; M Rossini
Journal:  Rheumatology (Oxford)       Date:  2007-03-23       Impact factor: 7.580

6.  Kinetics of degradation of imidapril hydrochloride in finished dosage formulations.

Authors:  Beata Stanisz; Katarzyna Regulska
Journal:  Acta Pol Pharm       Date:  2013 Jul-Aug       Impact factor: 0.330

7.  Determination and validation of six sunscreen agents in suncare products by UPLC and HPLC.

Authors:  So-Mi Lee; Hye-Jin Jeong; Ih Seop Chang
Journal:  J Cosmet Sci       Date:  2008 Nov-Dec       Impact factor: 0.948

8.  Binding of the anti-inflammatory steroid deflazacort to glucocorticoid receptors in brain and peripheral tissues. In vivo and in vitro studies.

Authors:  H Coirini; D Flores; M C Vega; M C Gonzalez Deniselle; A F De Nicola
Journal:  J Steroid Biochem Mol Biol       Date:  1994-05       Impact factor: 4.292

9.  Determination of deflazacort in human plasma by liquid chromatography-mass spectrometry after liquid-liquid extraction and its application in human pharmacokinetics studies.

Authors:  Muralidharan Selvadurai; Subramania Nainar Meyyanathan
Journal:  Pharm Methods       Date:  2011-04

10.  Stress Degradation Behavior of Abacavir Sulfate and Development of a Suitable Stability-Indicating UHPLC Method for the Determination of Abacavir, its Related Substances, and Degradation Products.

Authors:  Pallavi Vukkum; Girish R Deshpande; J Moses Babu; R Muralikrishna; Pavani Jagu
Journal:  Sci Pharm       Date:  2012-07-27
View more
  1 in total

Review 1.  Comparative Stability of Two Anti-hyperpigmentation Agents: Kojic Acid as a Natural Metabolite and Its Di-Palmitate Ester, Under Oxidative Stress; Application to Pharmaceutical Formulation Design.

Authors:  Sahar Tazesh; Elnaz Tamizi; Mohammadreza Siahi Shadbad; Nazli Mostaghimi; Farnaz Monajjemzadeh
Journal:  Adv Pharm Bull       Date:  2021-05-30
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.